TScan Therapeutics (NASDAQ:TCRX) Receives Notice for Conversion of $15 Million Loan into Common Stock

TScan Therapeutics, Inc. recently disclosed in an 8-K filing to the Securities and Exchange Commission that the company has received a conversion notice from a lender. The lender, as per the notice, has opted to convert $15 million of the principal amount of the loan into voting common stock of TScan Therapeutics. The conversion was […]

Leave a Reply

Your email address will not be published.

Previous post TKO Group Holdings, Inc. Refinances Existing Credit Agreement
Next post Addentax Group (NASDAQ: ATXG) Signs MOU with Yingbin Brand for Strategic Collaboration